regenerx.investorroom.com regenerx.investorroom.com

regenerx.investorroom.com

RegeneRx Investors - Overview

Pipeline / Clinical Trials. To develop and commercialize novel pharmaceutical products that prevent or repair tissue and organ damage caused by disease, trauma, or other pathology. More. View Letter to Shareholders. Aug 12, 2015. New Publication Elaborates on TB4's Effects on Dry Eye Syndrome and Other Potential Ophthalmic Disorders. Aug 6, 2015. RegeneRx Provides Update on Clinical Trials in U.S., Korea and China. Jul 22, 2015. No events to display. July 15, 2014. July 7, 2014. June 23, 2014.

http://regenerx.investorroom.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR REGENERX.INVESTORROOM.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

May

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Thursday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.9 out of 5 with 7 reviews
5 star
2
4 star
4
3 star
0
2 star
0
1 star
1

Hey there! Start your review of regenerx.investorroom.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

1.4 seconds

CONTACTS AT REGENERX.INVESTORROOM.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
RegeneRx Investors - Overview | regenerx.investorroom.com Reviews
<META>
DESCRIPTION
Pipeline / Clinical Trials. To develop and commercialize novel pharmaceutical products that prevent or repair tissue and organ damage caused by disease, trauma, or other pathology. More. View Letter to Shareholders. Aug 12, 2015. New Publication Elaborates on TB4's Effects on Dry Eye Syndrome and Other Potential Ophthalmic Disorders. Aug 6, 2015. RegeneRx Provides Update on Clinical Trials in U.S., Korea and China. Jul 22, 2015. No events to display. July 15, 2014. July 7, 2014. June 23, 2014.
<META>
KEYWORDS
1 sharethis
2 company overview
3 science and discovery
4 business development
5 investors
6 overview
7 stock data
8 analyst coverage
9 governance
10 sec filings
CONTENT
Page content here
KEYWORDS ON
PAGE
sharethis,company overview,science and discovery,business development,investors,overview,stock data,analyst coverage,governance,sec filings,news and events,presentations,fundamentals,info req,our mission,price data,otcqb,rgrx,recent news,upcoming events
SERVER
Apache
CONTENT-TYPE
iso-8859-1
GOOGLE PREVIEW

RegeneRx Investors - Overview | regenerx.investorroom.com Reviews

https://regenerx.investorroom.com

Pipeline / Clinical Trials. To develop and commercialize novel pharmaceutical products that prevent or repair tissue and organ damage caused by disease, trauma, or other pathology. More. View Letter to Shareholders. Aug 12, 2015. New Publication Elaborates on TB4's Effects on Dry Eye Syndrome and Other Potential Ophthalmic Disorders. Aug 6, 2015. RegeneRx Provides Update on Clinical Trials in U.S., Korea and China. Jul 22, 2015. No events to display. July 15, 2014. July 7, 2014. June 23, 2014.

OTHER SITES

regenerus.org.uk regenerus.org.uk

Regenerus

Ice Cream Van Tour. Media on the Mersey. Ice Cream Van Tour. Media on the Mersey. Regenerus provides a wide range of support services to new and existing businesses. as well as pre-employment training and professional development and business skills training. We're also involved in a number of important community and heritage projects. Have your say about the future of Crosby's Carnegie Library. Read our latest press release - click here. Complete our Carnegie Library survey - click here. The closing dat...

regeneruslabs.com regeneruslabs.com

Homepage | Regenerus Laboratories

Audio / Video Recordings. Do I need a blood draw. Where to get a blood collection. Using the post office. We represent over 15 different laboratories , provide more than 200 different tests, and deliver internationally accredited laboratory testing services to the doorstep of health professionals and their patients. Full UK and Ireland Coverage is available Monday to Friday. Normal working hours are 9am to 5pm. Just some of our happy customers :). The info this team holds is amazing! We don't analyse any...

regenerv.ro regenerv.ro

Regenerv - Pagina principala

FOLOSIREA DE CONDUCTORI BIOARTIFICIALI INSAMANTATI PRIN TEHNICI DE INGINERIE TISULARA CU CELULE SCHWANN CA METODA ALTERNATIVA IN REPARAREA LEZIUNILOR DE NERVI PERIFERICI. UNIVERSITATEA DE MEDICINA SI FARMACIE CAROL DAVILA BUCURESTI. Consiliul National al Cercetarii Stiintifice din Invatamantul Superior. Unitatea Executiva pentru Finantarea Invatamantului Superior si a Cercetarii Stiintifice Universitare, CNCSIS-UEFISCSU. Prof Dr. Ioan Lascar.

regenervate.com regenervate.com

Injection Therapy | Regenerative Medicine | RegenerVate | Canada

Calf / Lower Leg. Sign Up For Our Monthly. We use your body's own healing potential to help itself. Our skilled injection therapy doctors are highly trained and use regenerative medicine to treat injuries. RegenerVate Medical Injection Therapy treats a wide variety of conditions including arthritis, cartilage tears and tendon tears, which may produce pain. Read more for a full list. Dr Douglas W. Stoddard, RegenerVate's Medical Director, explains. Where to find us. North American Toll Free:.

regenerx.com regenerx.com

Utilizing Thymosin Beta 4 (Tβ4) to develop drug candidates in three principal areas: dermal, ophthalmic, and cardiovascular wound healing. - RegeneRx

Pipeline / Clinical Trials. SNNLive interview with J.J. Finkelstein, President and CEO of RegeneRx Biopharmaceuticals, Inc. at the 4th Annual SeeThruEquity MicroCap Investor Conference 2015 in New York City, NY. Watch the video interview. Shareholder letter - Tuesday February 17, 2015. August 12, 2015. New Publication Elaborates on TB4's Effects on Dry Eye Syndrome and Other Potential Ophthalmic Disorders. August 6, 2015. RegeneRx Provides Update on Clinical Trials in U.S., Korea and China. July 22, 2015.

regenerx.investorroom.com regenerx.investorroom.com

RegeneRx Investors - Overview

Pipeline / Clinical Trials. To develop and commercialize novel pharmaceutical products that prevent or repair tissue and organ damage caused by disease, trauma, or other pathology. More. View Letter to Shareholders. Aug 12, 2015. New Publication Elaborates on TB4's Effects on Dry Eye Syndrome and Other Potential Ophthalmic Disorders. Aug 6, 2015. RegeneRx Provides Update on Clinical Trials in U.S., Korea and China. Jul 22, 2015. No events to display. July 15, 2014. July 7, 2014. June 23, 2014.

regenerxx.com regenerxx.com

Index of /

Apache Server at www.regenerxx.com Port 80.

regenerxxl.com regenerxxl.com

regenerxxl.com

Inquire about this domain.

regenery.com regenery.com

NetBeat Webhosting - www.netbeat.de

Wir wuenschen Ihnen viel Spaß mit NetBeat Webhosting.

regenerys.com regenerys.com

Home – Regenerys

Innovative solutions for regenerative medicine. Regenerys is a regenerative medicine company working with adipose tissue for breast reconstruction and plastic surgery, and in skin regeneration technology. We are HTA and MHRA licenced and are built on solid pillars of quality, regulatory compliance and experienced staff. The leadership team is advised by pre-eminent clinicians. Welcome to the new site! June 15, 2015. 2015 Regenerys Ltd. tel: 0114 222 0989 email: info@regenerys.com.

regenes.com regenes.com

TopDomainer Search Engine

3,50000 €. 7,08000 €. 1,00000 €. 20,000.00 €. 7,00000 €. 30,000.00 €. 5,90000 €. 20,000.00 €. 8,26000 €. 1,00000 €. 20,000.00 €. 30,000.00 €. 4,72000 €. 2,78500 €. 9,74700 €. 3,54000 €. 5,90000 €. 3,54000 €. 3,54000 €. 18,000.00 €. 5,31000 €. 4,13000 €. 4,72000 €. 18,000.00 €. 4,13000 €. 7,08000 €. 7,08000 €. 3,54000 €. 5,29000 €. 5,31000 €. 4,17700 €. 7,08000 €. 4,13000 €. 5,31000 €. 5,31000 €. 14,160.00 €. 5,90000 €. 8,54000 €. 3,54000 €. 5,31000 €. 3,54000 €. 2,95000 €. 5,90000 €. 5,31000 €. 4,13000 &...